See the inflammation markers behind your skin
Check inflammation, hormone, and metabolic markers in one blood panel
- CLIA-certified labs
- HIPAA compliant
- Personalized health protocol
What are acne scars?
Acne scars are the lasting changes in skin texture left behind after an inflammatory acne lesion damages the skin and the body repairs the damage, appearing either as a depressed (atrophic) dent or a raised (hypertrophic or keloidal) bump. Why one lesion heals invisibly while the next leaves a mark is still not fully understood, with several competing hypotheses.
Scarring is common because the condition behind it is. Acne is one of the most common skin conditions on earth, with roughly 231 million prevalent cases worldwide in 2019. Of the people who get it, about 47% across 37 studies and 24,649 patients end up with some degree of scarring, which is why so many people search for pockmarks, pitted scars, or indented scars long after the breakouts have stopped.
Scars vs. dark marks: why the difference matters
A true scar is a structural change in the contour of the skin. The flat brown or red patches left behind when a pimple clears are something else entirely: pigment and blood-vessel changes in otherwise intact skin, best described as a reactive hypermelanosis that follows skin inflammation.
That distinction is not academic, because the two respond to completely different things. Pigmentary marks answer to topical agents such as hydroquinone, retinoids, and azelaic acid, along with chemical peels and light-based devices, and unlike a true scar they commonly fade over months on their own. Most people who say their acne "scarred" are describing post-acne marks or dark spots rather than a change in texture.
What causes acne scars to form?
Acne scars form when inflammation from a deep or long-lived lesion damages the dermis and the repair process lays down either too little collagen, leaving a depression, or too much, leaving a raised scar. Both outcomes trace back to the inflammatory acne lesion that preceded them.
The timeline is shorter than most people assume. Scars accumulate over months of untreated inflammatory acne, not years: in a six-month split-face trial, atrophic scar counts rose about 25% on the untreated side while staying stable where the acne was being managed. The window to influence whether scarring happens at all is open while the acne is still active, not after it settles.
Who is most likely to scar
Scarring risk is not random. It tracks a handful of measurable factors that clinicians can see coming:
- Acne severity. Severe acne carries odds of scarring 5.51 times higher, and moderate acne 2.34 times higher, than milder disease.
- Male sex. Men carry 1.58 times the odds of scarring in the same pooled analysis.
- Family history. A positive family history of acne raises the odds 2.73 times.
- Early onset and younger age. Adolescent-onset acne and a younger age at presentation both predicted more scarring in a clinical study of 269 patients, 71.3% of whom had scars.
- Lingering marks. Post-lesional hyperpigmentation and erythema that hang around predicted more severe scarring in that same group.
Those two studies report different headline rates, roughly 47% pooled versus 71.3% in one clinic population, because the populations and severity mixes differ. Take the range as a signal of who is being counted, not as a contradiction.
The types of acne scars
Acne scars sort into three buckets: depressed, raised, and flat marks that are not technically scars at all. The atrophic and hypertrophic split is the one that matters most, because the bucket a scar falls into sets the ceiling on what any treatment can realistically do.
Depressed scars: ice pick, boxcar, and rolling
Depressed (atrophic) scars are indentations left where healing skin produced too little collagen, and they are the most common outcome of inflammatory acne. They divide into three distinct morphologies:
- Ice pick scars are narrow, deep, V-shaped tracks that taper to a point in the dermis. They are the deepest of the three relative to their width, often less than 2 mm across, and are common on the cheeks.
- Boxcar scars are wider, round or oval depressions with sharply defined vertical walls, giving them a punched-out look. Depth varies from shallow to severe, and they appear most often on the cheeks and temples.
- Rolling scars are broad, shallow undulations that give the skin a wavy surface. Fibrous tethers beneath the skin pull the surface down, so the shadow shifts with the light, and the lower cheeks and jawline are typical sites.
Because each subtype has a different structural cause, care gets selected by scar shape rather than by severity alone, and that principle underpins the standard multimodality approach tailored to scar type.
Raised scars: hypertrophic, keloid, and papular
Raised scars form when repair overshoots and excess collagen is deposited, leaving firm elevated tissue instead of a dent.
- Hypertrophic scars are firm, raised, and pink to skin-colored, and they stay within the borders of the original lesion. They are the more contained of the two raised types and often flatten somewhat over time.
- Keloids extend beyond the borders of the original lesion into surrounding skin, can itch or feel tender, and are notably prone to recurrence after removal.
- Papular scars are soft, small, skin-colored or hypopigmented bumps, usually only a few millimeters across. They are subtle enough to be mistaken for active lesions and show up most often on the upper trunk.
Raised scars occur predominantly on the trunk, which is why scarring below the neck often behaves differently from scarring on the face. The treatment path diverges too: silicone gel or sheeting with corticosteroid injection is supported as first-line care, with excision plus immediate post-excision radiation reserved for stubborn keloids.
Flat marks: post-inflammatory hyperpigmentation and erythema
Acne inflammation leaves two distinct flat marks, and neither is a true scar: post-inflammatory hyperpigmentation and erythema, brown or gray-brown in the first case and pink or red in the second.
Which one you get depends largely on skin tone. Hyperpigmentation is more common in Fitzpatrick skin types III to VI while erythema is more common in lighter skin, and both can linger long enough that people often find the marks more distressing than the acne itself. For the red marks specifically, vascular laser and light devices plus certain topicals show benefit on a still-thin evidence base that calls for more randomized trials.
How dermatologists grade acne scarring
Dermatologists grade post-acne scarring on a four-point qualitative global scale that runs from macular through mild, moderate, and severe. Grade one is flat discoloration only. Grades two through four escalate by lesion morphology combined with disease load, judged in a refreshingly practical way: whether makeup covers the scarring, and whether it is visible at conversational distance.
The grade is not a label for its own sake. It maps directly onto which intervention is appropriate, so a grading conversation is the step that comes before any decision about a procedure.
What actually works for acne scars
No single treatment addresses every scar type, and combination approaches generally outperform single modalities, which is why most plans stack procedures against scar type. Worth saying plainly, because the marketing rarely does: treatment reduces the appearance of acne scars. It does not erase them.
At-home ingredients and what the evidence shows
The strongest at-home evidence is preventive rather than corrective. Over 24 weeks, a fixed adapalene 0.3%/benzoyl peroxide 2.5% gel cut total atrophic scar count by 15.5% while counts rose 14.4% on the untreated side, and 32.9% versus 16.4% of subjects were rated clear or almost clear on a scar global assessment. These are topical acne treatments used under clinical guidance, not products anyone should start on a hunch.
On the pigment side, the documented options for post-inflammatory hyperpigmentation are hydroquinone, retinoids, and azelaic acid. Daily photoprotection is the one at-home behavior with support for stabilizing and improving pigmentary change, particularly in skin of color, where visible light matters as much as UV.
The boundary is worth drawing clearly: no topical resurfaces an established depressed scar. At-home care earns its place by lowering the risk of new scars and improving discoloration.
In-office procedures matched to scar type
Procedure choice follows scar morphology, which is why the same clinic will offer four different answers to four people with the same acne history.
| Scar type | First-line in-office procedure | What the evidence reports | Realistic expectation |
|---|---|---|---|
| Rolling | Subcision to release the fibrous tethers | Safe and effective across 16 reviewed clinical trials, with cannula and needle techniques comparably effective | Combining subcision with filler, microneedling, or suction improves results and limits re-depression |
| Boxcar and mixed atrophic | Fractional laser resurfacing | Most patients across seven studies saw 30% to 70% improvement; CO2 beat Er:YAG on effective rate at an odds ratio of 1.81 | CO2 offers shorter downtime but more pain and longer-lasting erythema |
| Broad atrophic scarring | Microneedling | Consistently efficacious across nine randomized trials, alone or combined, with no serious adverse effects | Authors still call for larger samples and longer follow-up |
| Depressed scars needing volume | Hyaluronic acid filler | Reduced scar volume in a split-face randomized trial | Timing of visible effect differs by product |
| Hypertrophic and keloid | Silicone gel or sheeting with intralesional corticosteroid | Supported as first-line across 108 prospective studies | Excision with post-excision radiation is held back for recalcitrant lesions |
Chemical peels tend to be used alongside these procedures rather than instead of them. In one randomized trial, microneedling with a 35% glycolic acid peel and microneedling with a 15% trichloroacetic acid peel were similarly effective, with better texture improvement in the glycolic arm.
Add-ons follow the same logic. Layering platelet-rich plasma onto microneedling raised the odds of greater-than-50% improvement to 2.97, and the odds of patient satisfaction to 4.15, with no significant difference in severe erythema or edema between arms. Across resurfacing procedures generally, side effects include transient erythema, swelling, and post-inflammatory hyperpigmentation that typically resolve within weeks.
What the evidence does not support
Several widely promoted options for acne scars rest on weak or absent evidence, and the gap between the best-supported and least-supported modalities is wide. Graded evaluation puts fractional lasers and radiofrequency at the top for atrophic scars with minimal risk, while several popular alternatives sit on thin ground.
Kitchen-cupboard remedies, lemon juice, baking soda, coconut oil, and toothpaste among them, have no controlled trial evidence for resurfacing an established scar. Even the combination approach that clinics treat as standard rests on a minimal literature and substantial expert experience. None of that makes these options useless. "No evidence yet" and "proven useless" are different verdicts, and they are worth keeping apart.
How long do acne scars take to fade?
Flat post-acne marks generally fade over months as excess pigment clears and dilated vessels settle, because these marks are a reactive pigment change rather than a structural one. True depressed and raised scars behave differently: they are changes in the architecture of the skin, and they do not resolve on their own. They change only with treatment.
Treatment timelines run in sessions, not visits. Effect timing varies even within a single modality: in a split-face filler trial, a traditional cross-linked hyaluronic acid filler reduced scar volume early while a biostimulatory complex produced more pronounced improvement at later visits.
How to reduce the risk of acne scars in the first place
The best-supported way to reduce the risk of acne scars is to manage active inflammatory acne early and well, which measurably lowered scar counts in a 24-week randomized trial. Systemic isotretinoin was also protective against scarring in clinic data, though that is a conversation to have with a dermatologist rather than a conclusion to act on alone.
A practical sequence looks like this:
- Manage active inflammatory acne early and consistently rather than waiting for it to burn itself out.
- Escalate to clinician-guided care when lesions are deep, painful, or persistent, since moderate and severe acne carry the steepest odds.
- Protect the skin from sun every day, which helps stabilize and improve post-inflammatory pigmentation.
- Leave lesions alone instead of squeezing or picking them.
What makes acne scarring worse
A few specific, modifiable behaviors and skin responses independently raise the odds of scarring, and they are the ones most within a person's control:
- Squeezing and picking lesions, which carried adjusted odds of 2.69 for facial acne scarring.
- Persistent post-acne erythema, at adjusted odds of 4.46 in the same analysis.
- Untreated moderate acne (odds 3.51) and severe to very severe acne (odds 8.98), the steepest risk in the set.
- Sun exposure, which prolongs and deepens post-inflammatory pigmentation.
When to see a dermatologist, and what to ask
Waiting until scarring is severe enough to "deserve" attention is a mistake the data does not support. In a population-based survey of 723 adults with facial acne scars and no active acne, quality-of-life impact rose with severity, but even mild scarring carried significant impact, with 74.8% reporting worry that the scars would not go away and 68.0% reporting self-consciousness. Active breakouts, deep or painful lesions, and any raised scar creeping past its original border all warrant a clinician's assessment rather than self-treatment.
Five questions make a consultation more useful:
- Which scar types do I have, and how would you grade them?
- Which procedures suit those specific types?
- How many sessions are realistic, and what improvement range does the evidence support?
- What side effects and downtime should I expect, and how long do they last?
- Does my active acne need controlling before we start?
Check the inflammation behind acne scars with a Superpower blood panel
Acne scars are the visible record of inflammation that has already run its course. Scar treatment belongs with a dermatologist, but the systemic picture underneath the skin, including inflammation, hormone, metabolic, and nutrient markers, is measurable long before anything shows on the surface. The Superpower Blood Panel covers that baseline. See what Superpower measures across inflammation, hormone, metabolic, and nutrient biomarkers.
Frequently Asked Questions
References
- Fabbrocini G, Annunziata MC, D'Arco V, et al. (2010). Acne scars: pathogenesis, classification and treatment. *Dermatology Research and Practice*, *2010*, 893080. https://doi.org/10.1155/2010/893080
- Chen H, Zhang TC, Yin XL, et al. (2022). Magnitude and temporal trend of acne vulgaris burden in 204 countries and territories from 1990 to 2019: an analysis from the Global Burden of Disease Study 2019. *British Journal of Dermatology*, *186*(4), 673–683. https://doi.org/10.1111/bjd.20882
- Liu L, Xue Y, Chen Y, et al. (2023). Prevalence and risk factors of acne scars in patients with acne vulgaris. *Skin Research and Technology*, *29*(6), e13386. https://doi.org/10.1111/srt.13386
- Kaufman BP, Aman T, Alexis AF (2018). Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. *American Journal of Clinical Dermatology*, *19*(4), 489–503. https://doi.org/10.1007/s40257-017-0333-6
- Dréno B, Tan J, Rivier M, Martel P, Bissonnette R (2017). Adapalene 0.1%/benzoyl peroxide 2.5% gel reduces the risk of atrophic scar formation in moderate inflammatory acne: a split-face randomized controlled trial. *Journal of the European Academy of Dermatology and Venereology*, *31*(4), 737–742. https://doi.org/10.1111/jdv.14026
- Etgu F, Sekerlisoy Tatar G (2025). Risk factors and epidemiology of acne severity and acne scar development: a comprehensive clinical study. *Dermatology Practical & Conceptual*, *15*(4), e20256108. https://doi.org/10.5826/dpc.1504a6108
- Jacob CI, Dover JS, Kaminer MS (2001). Acne scarring: a classification system and review of treatment options. *Journal of the American Academy of Dermatology*, *45*(1), 109–117. https://doi.org/10.1067/mjd.2001.113451
- Wilson BB, Dent CH, Cooper PH (1990). Papular acne scars: a common cutaneous finding. *Archives of Dermatology*, *126*(6), 797–800.
- Boen M, Jacob C (2019). A review and update of treatment options using the acne scar classification system. *Dermatologic Surgery*, *45*(3), 411–422. https://doi.org/10.1097/DSS.0000000000001765
- Zaleski-Larsen LA, Fabi SG, McGraw T, Taylor M (2016). Acne scar treatment: a multimodality approach tailored to scar type. *Dermatologic Surgery*, *42*(Suppl 2), S139–S149. https://doi.org/10.1097/DSS.0000000000000746
- Walsh LA, Wu E, Pontes D, et al. (2023). Keloid treatments: an evidence-based systematic review of recent advances. *Systematic Reviews*, *12*(1), 42. https://doi.org/10.1186/s13643-023-02192-7
- Elbuluk N, Grimes P, Chien A, et al. (2021). The pathogenesis and management of acne-induced post-inflammatory hyperpigmentation. *American Journal of Clinical Dermatology*, *22*(6), 829–836. https://doi.org/10.1007/s40257-021-00633-4
- Kalantari Y, Dadkhahfar S, Etesami I (2022). Post-acne erythema treatment: a systematic review of the literature. *Journal of Cosmetic Dermatology*, *21*(4), 1379–1392. https://doi.org/10.1111/jocd.14804
- Goodman GJ, Baron JA (2006). Postacne scarring: a qualitative global scarring grading system. *Dermatologic Surgery*, *32*(12), 1458–1466. https://doi.org/10.1111/j.1524-4725.2006.32354.x
- Bhargava S, Cunha PR, Lee J, Kroumpouzos G (2018). Acne scarring management: systematic review and evaluation of the evidence. *American Journal of Clinical Dermatology*, *19*(4), 459–477. https://doi.org/10.1007/s40257-018-0358-5
- Dréno B, Bissonnette R, Gagné-Henley A, et al. (2018). Prevention and reduction of atrophic acne scars with adapalene 0.3%/benzoyl peroxide 2.5% gel in subjects with moderate or severe facial acne: results of a 6-month randomized, vehicle-controlled trial using intra-individual comparison. *American Journal of Clinical Dermatology*, *19*(2), 275–286. https://doi.org/10.1007/s40257-018-0352-y
- Fatima S, Braunberger T, Mohammad TF, Kohli I, Hamzavi IH (2020). The role of sunscreen in melasma and postinflammatory hyperpigmentation. *Indian Journal of Dermatology*, *65*(1), 5–10. https://doi.org/10.4103/ijd.IJD_295_18
- Ahramiyanpour N, Rastaghi F, Parvar SY, et al. (2023). Subcision in acne scarring: a review of clinical trials. *Journal of Cosmetic Dermatology*, *22*(3), 744–751. https://doi.org/10.1111/jocd.15480
- Ptaszek B, Czernecka M, Podsiadło S (2025). The use of a fractional laser in acne scar treatment — a systematic review. *Life*, *15*(6), 915. https://doi.org/10.3390/life15060915
- Liu F, Zhou Q, Tao M, Shu L, Cao Y (2024). Efficacy and safety of CO2 fractional laser versus Er:YAG fractional laser in the treatment of atrophic acne scar: a meta-analysis and systematic review. *Journal of Cosmetic Dermatology*, *23*(9), 2768–2778. https://doi.org/10.1111/jocd.16348
- Sitohang IBS, Sirait SAP, Suryanegara J (2021). Microneedling in the treatment of atrophic scars: a systematic review of randomised controlled trials. *International Wound Journal*, *18*(5), 577–585. https://doi.org/10.1111/iwj.13559
- Mehrabi J, Shehadeh W, Gallo ES, Artzi O, Horovitz T (2023). Comparison of 2 hyaluronic acid-based fillers for the treatment of acne scars: structural lifting versus biostimulatory effect. *Dermatologic Surgery*, *49*(6), 581–586. https://doi.org/10.1097/DSS.0000000000003789
- Dayal S, Kaur R, Sahu P (2022). Efficacy of microneedling with 35% glycolic acid peels versus microneedling with 15% trichloroacetic acid peels in treatment of atrophic acne scars: a randomized controlled trial. *Dermatologic Surgery*, *48*(11), 1203–1209. https://doi.org/10.1097/DSS.0000000000003556
- Kang C, Lu D (2022). Combined effect of microneedling and platelet-rich plasma for the treatment of acne scars: a meta-analysis. *Frontiers in Medicine*, *8*, 788754. https://doi.org/10.3389/fmed.2021.788754
- Yan C, Phinyo P, Yogya Y, Chuamanochan M, Wanitphakdeedecha R (2025). Risk factors associated with facial acne scarring in Thai patients with acne: a cross-sectional study. *Journal of Cosmetic Dermatology*, *24*(1), e16695. https://doi.org/10.1111/jocd.16695
- Tan J, Beissert S, Cook-Bolden F, et al. (2022). Impact of facial atrophic acne scars on quality of life: a multi-country population-based survey. *American Journal of Clinical Dermatology*, *23*(1), 115–123. https://doi.org/10.1007/s40257-021-00628-1















